Protease Inhibitors

Links shared publicly online about this topic

Neurology Article | Protease Inhibitors

mdlinx.com — “Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse EventsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 9, 2011 at 8:31 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Advers... http://bit.ly/jXIxyc #neuro

9 months ago...

Oncology Article | Protease Inhibitors

mdlinx.com — “Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adverse EventsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 9, 2011 at 3:50 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Nonproteasomal Targets of the Proteasome Inhibitors Bortezomib and Carfilzomib: a Link to Clinical Adv... http://bit.ly/jH5yqf #oncology

9 months ago...

Oncology Article | Protease Inhibitors

mdlinx.com — “Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via induction of FOXO1 and p27Kip1View full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 28, 2011 at 6:03 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Resveratrol protects leukemic cells against cytotoxicity induced by proteasome inhibitors via inductio... http://bit.ly/f9AIEf #oncology

10 months ago...

Family Medicine Article | Protease Inhibitors

mdlinx.com — “Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysisView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on December 16, 2010 at 8:21 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Protease inhibitors for preventing complications associated with ERCP: an updated meta-analysis: Ga... http://bit.ly/gX6zTf #FamPractice

1 year ago...

Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September)

theannals.com — “Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September)View full resource at theannals.com

  • View Related
  • Share

Most Recently Shared on August 10, 2011 at 4:57 am By:

theannals The Annals Medical Journal

Boceprevir: A Protease Inhibitor for the Treatment of Chronic Hepatitis C (September): OBJECTIVE:To review the p... http://bit.ly/rrZDSP

6 months ago...

HCV New Drug Research: Hepatitis C; resistance to protease inhibitors

hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C; resistance to protease inhibitorsView full resource at hepatitiscnewdrugs.blogspot.com

  • View Related
  • Share

Most Recently Shared on February 6, 2011 at 12:22 am By:

HCV New Drug Research: Protease Inhibitor-Resistant Hepatitis C Virus

hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Protease Inhibitor-Resistant Hepatitis C VirusView full resource at hepatitiscnewdrugs.blogspot.com

  • View Related
  • Share

Most Recently Shared on November 16, 2010 at 1:39 am By:

Gastroenterology Article | Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and Atorvastatin

mdlinx.com — “Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and AtorvastatinView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on September 28, 2011 at 9:28 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and Ator... http://t.co/PpLkeotL #GI

4 months ago...

HIV Protease Inhibitors: Present and Future - QualityPoint Technologies

qualitypointtech.net — “This article gives an overview of some of the newest protease inhibitors available for HIV infected patients. Future VirologyView full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on July 11, 2011 at 3:00 pm By:

MedicalFeed MedicalFeed Health News Feed

HIV Protease Inhibitors: Present and Future: This article gives an overview of some of the newest protease inhibit... http://bit.ly/psbQfq

7 months ago...

HCV New Drug Research: Hepatitis C; resistance to protease inhibitors

hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: Hepatitis C; resistance to protease inhibitorsView full resource at hepatitiscnewdrugs.blogspot.com

  • View Related
  • Share

Most Recently Shared on February 7, 2011 at 1:45 am By:

HCVNEWDRUGS Tina Banwart - HepatitisCNewDrugs Health Blog

HCV New Drug Research: Hepatitis C; resistance to protease inhibitors http://t.co/C8tN60i

1 year ago...

New Colcrys dosing when administered with protease inhibitors - ONA

oncologynurseadvisor.com — “URL Pharma, Inc., today announced that the FDA has issued new label information affecting all approved protease inhibitors for treatment of HIV when co-administered with Colcrys (colchicine).View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on May 7, 2010 at 2:55 pm By:

New Colcrys dosing when administered with protease inhibitors - MPR

empr.com — “URL Pharma, Inc., today announced that the FDA has issued new label information affecting all approved protease inhibitors for treatment of HIV when co-administered with Colcrys (colchicine).View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on May 7, 2010 at 3:59 pm By:

eMPR MPR Medical Publisher

MPR News: New Colcrys dosing when administered with protease inhibitors: URL Pharma, Inc., today announced that th... http://bit.ly/apQoWm

2 years ago...

Victrelis: protease inhibitor launched for hepatitis C | MIMS online

mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS onlineView full resource at mims.co.uk

  • View Related
  • Share

Most Recently Shared on August 30, 2011 at 3:56 pm By:

mimsonline MIMS Online Medical Publisher

Victrelis, first protease inhibitor for hepatitis C, now listed in MIMS: http://t.co/FlBPTMK

5 months ago...

Incivo: hepatitis C protease inhibitor launched | MIMS online

mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS onlineView full resource at mims.co.uk

  • View Related
  • Share

Most Recently Shared on November 4, 2011 at 2:10 pm By:

mimsonline MIMS Online Medical Publisher

MIMS summary of Incivo (telaprevir), new hepatitis C protease inhibitor: http://t.co/h0ENYV6B

3 months ago...

HCV New Drug Research: HCV/Protease inhibitor BI 201335 and the polymerase inhibitor BI 207127

hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: HCV/Protease inhibitor BI 201335 and the polymerase inhibitor BI 207127View full resource at hepatitiscnewdrugs.blogspot.com

  • View Related
  • Share

Most Recently Shared on October 30, 2010 at 1:22 pm By:

HCVNEWDRUGS Tina Banwart - HepatitisCNewDrugs Health Blog

HCV/Protease inhibitor BI 201335 and the polymerase inhibitor BI 207127 http://goo.gl/fb/IsRuL

1 year ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

  • MDLinx

    Sandeep Pulim MD

    Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390